These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3263863)

  • 1. Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivo.
    Corsini GU; Bocchetta A; Zuddas A; Piccardi MP; Del Zompo M
    Biochem Pharmacol; 1988 Nov; 37(21):4163-9. PubMed ID: 3263863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase.
    Corsini GU; Pintus S; Bocchetta A; Piccardi MP; Del Zompo M
    J Pharmacol Exp Ther; 1986 Aug; 238(2):648-52. PubMed ID: 3488394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitro.
    Corsini GU; Pintus S; Bocchetta A; Piccardi MP; Del Zompo M
    J Neural Transm Suppl; 1986; 22():55-60. PubMed ID: 3097260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: binding and biochemical studies.
    Del Zompo M; Piccardi MP; Bernardi F; Bonuccelli U; Corsini GU
    Brain Res; 1986 Jul; 378(2):320-4. PubMed ID: 3089539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of monoamine oxidase inhibitors and a dopamine uptake blocker on the distribution of 11C-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 11C-MPTP, in the head of the rhesus monkey.
    Hartvig P; Larsson BS; Lindberg BS; Oreland L; Gullberg P; Långström B; Rimland A; Lundqvist H; Malmborg P; Lindquist NG
    Acta Neurol Scand; 1986 Jul; 74(1):10-6. PubMed ID: 3490110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Itzhak Y; Mash D; Zhang SH; Stein I
    Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase B(MAO-B) is the major catalyst for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation in human brain and other tissues.
    Glover V; Gibb C; Sandler M
    Neurosci Lett; 1986 Feb; 64(2):216-20. PubMed ID: 3083305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase B.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    J Neurochem; 1985 Oct; 45(4):1049-54. PubMed ID: 3928814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs.
    Youngster SK; Sonsalla PK; Sieber BA; Heikkila RE
    J Pharmacol Exp Ther; 1989 Jun; 249(3):820-8. PubMed ID: 2786564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization in rat brain of binding sites for parkinsonian toxin MPTP: similarities with [3H]pargyline binding to monoamine oxidase.
    Rainbow TC; Parsons B; Wieczorek CM; Manaker S
    Brain Res; 1985 Mar; 330(2):337-42. PubMed ID: 3872699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
    Sonsalla PK; Youngster SK; Kindt MV; Heikkila RE
    J Pharmacol Exp Ther; 1987 Sep; 242(3):850-7. PubMed ID: 2888874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of [14C]MPTP in mouse and monkey implicates MPP+, and not bound metabolites, as the operative neurotoxin.
    Yang SC; Johannessen JN; Markey SP
    Chem Res Toxicol; 1988; 1(4):228-33. PubMed ID: 2979736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver.
    Riachi NJ; Harik SI; Kalaria RN; Sayre LM
    J Pharmacol Exp Ther; 1988 Feb; 244(2):443-8. PubMed ID: 3258032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pargyline prevents MPTP-induced parkinsonism in primates.
    Langston JW; Irwin I; Langston EB; Forno LS
    Science; 1984 Sep; 225(4669):1480-2. PubMed ID: 6332378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in experimental animals studied by postiron emission tomography and whole body autoradiography.
    Hartvig P; Lindquist NG; Aquilonius SM; d'Argy R; Bergström K; Bondesson U; Eckernäs SA; Gullberg P; Larsson BS; Lindberg B
    Life Sci; 1986 Jan; 38(1):89-97. PubMed ID: 3484535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation by rat brain of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) coupled to tetrazolium nitro blue.
    Youdim MB
    Eur J Pharmacol; 1985 Jul; 113(2):283-6. PubMed ID: 3876227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity.
    Kalaria RN; Mitchell MJ; Harik SI
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3521-5. PubMed ID: 3495000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.